Bradley N. Collins and Stephen J. Lepore are with the Department of Social and Behavioral Sciences, College of Public Health, Temple University, Philadelphia, PA. Brian L. Egleston is with the Biostatistics and Bioinformatics Facility, Fox Chase Cancer Center, Philadelphia, PA.
Am J Public Health. 2022 Mar;112(3):472-481. doi: 10.2105/AJPH.2021.306601.
To test the efficacy of Babies Living Safe and Smokefree (BLiSS), a multilevel intervention initiated in a citywide safety net health system to improve low-income maternal smokers' abstinence and reduce child tobacco smoke exposure. This randomized controlled trial in Philadelphia, Pennsylvania (2015-2020), recruited low-income maternal smokers who received a brief smoking intervention (Ask, Advise, Refer [AAR]) from nutrition professionals in the Special Supplemental Nutrition Program for Women, Infants, and Children before randomization to (1) a multilevel intervention (AAR + multimodal behavioral intervention [MBI]; n = 199) or (2) an attention control intervention (AAR + control; n = 197). AAR + MBI mothers had significantly higher 12-month bioverified abstinence rates than did AAR + control mothers (odds ratio [OR] = 9.55; 95% confidence interval [CI] = 1.54, 59.30; = .015). There were significant effects of time (b = -0.15; SE = 0.04; < .001) and condition by time (b = -0.19; SE = 0.06; < .001) on reported child exposure favoring AAR + MBI, but no group difference in child cotinine. Presence of other residential smokers was related to higher exposure. Higher baseline nicotine dependence was related to higher child exposure and lower abstinence likelihood at follow-up. The multilevel BLiSS intervention was acceptable and efficacious in a population that experiences elevated challenges with cessation. BLiSS is a translatable intervention model that can successfully improve efforts to address the persistent tobacco-related burdens in low-income communities. Clinical Trials.gov identifier: NCT02602288. (. 2022;112(3):472-481. https://doi.org/10.2105/AJPH.2021.306601).
为了测试 Babies Living Safe and Smokefree (BLiSS) 的疗效,我们在一个全市范围的安全网健康系统中发起了一项多层次干预措施,以提高低收入产妇吸烟者的戒烟率并减少儿童的烟草烟雾暴露。这项在宾夕法尼亚州费城进行的随机对照试验(2015-2020 年)招募了低收入产妇吸烟者,她们在随机分组前接受了特殊补充营养计划(妇女、婴儿和儿童)营养专业人员提供的简短吸烟干预(询问、建议、转介 [AAR]),(1)接受多层次干预(AAR+多模式行为干预 [MBI];n=199)或(2)接受对照干预(AAR+对照;n=197)。与 AAR+对照组的母亲相比,AAR+MBI 组的母亲在 12 个月时的生物验证戒烟率显著更高(优势比 [OR] = 9.55;95%置信区间 [CI] = 1.54, 59.30;=.015)。时间(b=-0.15;SE=0.04; < .001)和条件与时间的交互作用(b=-0.19;SE=0.06; < .001)对报告的儿童暴露有显著影响,有利于 AAR+MBI,但两组儿童可替宁水平无差异。其他居住者吸烟与更高的暴露水平有关。较高的基线尼古丁依赖与较高的儿童暴露和随访时较低的戒烟可能性有关。多层次的 BLiSS 干预在一个面临持续戒烟挑战的人群中是可以接受和有效的。BLiSS 是一种可转化的干预模式,可以成功地改善解决低收入社区中持续存在的与烟草相关的负担的努力。临床试验.gov 标识符:NCT02602288。[2022;112(3):472-481. https://doi.org/10.2105/AJPH.2021.306601)。